The UCLA Biodesign Hub for MedTech and Digital Health (UCLA Biodesign) is seeking executives from medical technology and digital health companies to participate in a new study focused on advancing regulatory and reimbursement for innovative technologies. This study aims to establish benchmarks, educate regulators, and potentially influence future decision-making at a local and national level. In furtherance of increasing our healthcare system’s capacity to deliver MedTech and digital health innovations to patients and providers, we invite you to participate in UCLA Biodesign’s landmark study, Innovation in MedTech and Digital Health: A New Decade!
Read More